Thomas Jefferson University

Peter Kopelman

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kopelman P. Registration at the time of graduation. Clin Med (Lond). 2015 Jun; 15(3):220-1. PMID: 26031967.
      Citations:    
    2. Dietz WH, Baur LA, Hall K, Puhl RM, Taveras EM, Uauy R, Kopelman P. Management of obesity: improvement of health-care training and systems for prevention and care. Lancet. 2015 Jun 20; 385(9986):2521-33. PMID: 25703112.
      Citations:    
    3. Kopelman P. The future of UK medical education curriculum - what type of medical graduates do we need? Future Hosp J. 2014 Jun; 1(1):41-46. PMID: 31098043.
      Citations:    
    4. Carroll J, Goodair C, Chaytor A, Notley C, Ghodse H, Kopelman P. Substance misuse teaching in undergraduate medical education. BMC Med Educ. 2014 Feb 17; 14:34. PMID: 24533849.
      Citations:    
    5. Elder A, McAlpine L, Bateman N, Dacre J, Kopelman P, McManus C. Changing PACES: developments to the examination in 2009. Clin Med (Lond). 2011 Jun; 11(3):231-4. PMID: 21902073.
      Citations:    
    6. Kopelman P. Symposium 1: Overnutrition: consequences and solutions. Foresight Report: the obesity challenge ahead. Proc Nutr Soc. 2010 Feb; 69(1):80-5. PMID: 19954564.
      Citations:    
    7. Kopelman P, Groot Gde H, Rissanen A, Rossner S, Toubro S, Palmer R, Hallam R, Bryson A, Hickling RI. Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). Obesity (Silver Spring). 2010 Jan; 18(1):108-15. PMID: 19461584.
      Citations:    
    8. Grace C, Begum R, Subhani S, Kopelman P, Greenhalgh T. Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives. BMJ. 2008 Nov 04; 337:a1931. PMID: 18984633.
      Citations:    
    9. Mcalpine LG, Kopelman PG. MRCP(UK). Part 2. Clinical examination (PACES): examiners reflections. Clin Med (Lond). 2007 Aug; 7(4):417. PMID: 17882864.
      Citations:    
    10. Kopelman PG. Medical management of obesity. Br J Hosp Med (Lond). 2007 Feb; 68(2):89-93. PMID: 17370714.
      Citations:    
    11. Kopelman PG. Clinical treatment of obesity: are drugs and surgery the answer? Proc Nutr Soc. 2005 Feb; 64(1):65-71. PMID: 15877924.
      Citations:    
    12. Lawrence VJ, Kopelman PG. Medical consequences of obesity. Clin Dermatol. 2004 Jul-Aug; 22(4):296-302. PMID: 15475229.
      Citations:    
    13. Kopelman PG, Grace C. New thoughts on managing obesity. Gut. 2004 Jul; 53(7):1044-53. PMID: 15194659.
      Citations:    
    14. Kopelman P. The metabolic syndrome as a clinical problem. Nestle Nutr Workshop Ser Clin Perform Programme. 2004; 9:77-92. PMID: 15361680.
      Citations:    
    15. Chowdhury TA, Grace C, Kopelman PG. Preventing diabetes in south Asians. BMJ. 2003 Nov 08; 327(7423):1059-60. PMID: 14604901.
      Citations:    
    16. van Baak MA, van Mil E, Astrup AV, Finer N, Van Gaal LF, Hilsted J, Kopelman PG, R?ssner S, James WP, Saris WH. Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial). Am J Clin Nutr. 2003 Aug; 78(2):209-14. PMID: 12885699.
      Citations:    
    17. Uchegbu EC, Kopelman PG. Cardiovascular risks in obesity. J Endocrinol Invest. 2002 Nov; 25(10):915-8. PMID: 12508955.
      Citations:    
    18. Kopelman P, Lennard-Jones J. Nutrition and patients: a doctor's responsibility. Clin Med (Lond). 2002 Sep-Oct; 2(5):391-4. PMID: 12448582.
      Citations:    
    19. Kopelman PG, Finer N. Reply: Is obesity a disease? Int J Obes Relat Metab Disord. 2001 Oct; 25(10):1405-6. PMID: 11673758.
      Citations:    
    20. Kesaniemi YK, Danforth E, Jensen MD, Kopelman PG, Lef?bvre P, Reeder BA. Dose-response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc. 2001 Jun; 33(6 Suppl):S351-8. PMID: 11427759.
      Citations:    
    21. Cassell PG, Saker PJ, Huxtable SJ, Kousta E, Jackson AE, Hattersley AT, Frayling TM, Walker M, Kopelman PG, Ramachandran A, Snehelatha C, Hitman GA, McCarthy MI. Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia. 2000 Dec; 43(12):1558-64. PMID: 11151767.
      Citations:    
    22. Kopelman PG. Physiopathology of prolactin secretion in obesity. Int J Obes Relat Metab Disord. 2000 Jun; 24 Suppl 2:S104-8. PMID: 10997622.
      Citations:    
    23. Finer N, James WP, Kopelman PG, Lean ME, Williams G. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord. 2000 Mar; 24(3):306-13. PMID: 10757623.
      Citations:    
    24. Kopelman PG. Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity? J Endocrinol Invest. 1999 Jan; 22(1):76-9. PMID: 10090142.
      Citations:    
    25. Kopelman PG, Hitman GA. Diabetes. Exploding type II. Lancet. 1998 Dec 19-26; 352 Suppl 4:SIV5. PMID: 9872152.
      Citations:    
    26. Kopelman PG. Emerging management strategies for obesity. Int J Obes Relat Metab Disord. 1998 Aug; 22 Suppl 1:S7-11; discussion S12, S42. PMID: 9758238.
      Citations:    
    27. Kopelman PG. The effects of weight loss treatments on upper and lower body fat. Int J Obes Relat Metab Disord. 1997 Aug; 21(8):619-25. PMID: 15481759.
      Citations:    
    28. Kopelman PG, Sanderson AJ. Application of database systems in diabetes care. Med Inform (Lond). 1996 Oct-Dec; 21(4):259-71. PMID: 9244825.
      Citations:    
    29. Beales PL, Kopelman PG. Obesity genes. Clin Endocrinol (Oxf). 1996 Oct; 45(4):373-8. PMID: 8959072.
      Citations:    
    30. Kopelman PG, Finer N, Fox KR, Hill A, MacDonald IA. ASO consensus statement on obesity. UK Association for the Study of Obesity. Int J Obes Relat Metab Disord. 1994 Apr; 18(4):189-91. PMID: 8044191.
      Citations:    
    Kopelman's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (162)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _